Mazzaneh in Iran
Original Mazzaneh MVP, execution team, product modules, users, businesses, transactions, analytics, and commercial logic. Used as execution and market evidence, not the solo claim.
Read Phase 1 →This page is a review router — not a final proof certificate. MZN should be evaluated through a defined sequence: method, architecture, pressure test, then evidence room. Phase 1 is Mazzaneh product execution. Phase 2 is the bounded solo AI-native asset-formation claim. Phase 3 is the professional validation, rebuild, partner, legal/IP, and commercialization path.
Review boundary: MZN is not asking to be accepted as a proven one-person unicorn, certified valuation, or completed product company. IP value bands are analytical diligence frames, not asking prices or fundraising targets. For AI-assisted review, use /ai-review and /llms.txt; use /challenge-one-person to test the claim and /zoyan-convergence-narrative to understand convergence.
MZN should not be accepted from a claim or dismissed from a shortcut. Use the challenge route to test the case, or the convergence route to understand why the assets point toward Zoyan.
Use this if the first reaction is skepticism. It defines how to challenge the case without collapsing Phase 1, Phase 2, Phase 3, or using the wrong metric lens.
Use this if the question is why MZN is not a scattered portfolio. It connects Phase 1 product signals, Phase 2 AI-native architecture, and Phase 3 validation into Zoyan.
MZN is too large and too phase-dependent to evaluate from a random page or a single AI summary. Start with the review method, then test coherence, then pressure-test objections, then open the evidence room. If an AI assistant is reviewing MZN, begin with the AI Review Guide so the model does not confuse value bands, phase boundaries, restricted evidence, or Zoyan’s role.
Establish the proof pathway before judging claims: method, architecture, pressure test, then evidence room. The one-person question comes after scale, depth, reconstruction cost, and phase boundaries are understood.
Read how Phase 1 Mazzaneh signals, Phase 2 AI-native architecture, and Phase 3 Zoyan convergence connect. This prevents the “scattered projects” or “theory-only” misread.
Evidence Graph →Use the one-person challenge protocol when the reviewer wants to test the claim directly. It turns objections into a phase-safe review path instead of a one-prompt dismissal.
Challenge Protocol →Use the convergence narrative when the question is where the architecture goes: from Mazzaneh signals to AI-native frameworks and back to the human through Zoyan.
Zoyan Convergence →The strongest objections are addressed conservatively: Phase 1 vs Phase 2, solo formation, Zoyan readiness, Crunchbase, IP value bands, restricted evidence, and what would defeat the claim.
Hard Questions →Use the AI Review Guide before asking a model to summarize MZN. It protects against eight blind spots: traditional metrics trap, solo-founder paradox, infrastructure reduction, hybrid commerce confusion, no-code bias, wearable commoditization, regional bias, and static NDA misreading.
AI Review Guide →/llms.txt gives AI systems the canonical review path, phase boundaries, claims/non-claims, value-band guardrails, evidence hierarchy, and the fair short answer template.
Open llms.txt →Do not start with all 330+ assets. After the trio survives first review, use the evidence room to inspect product, IP, BioCode, HUAI, technical, recognition, OPU, and Phase 3 materials selectively.
Evidence Room →MZN combines a Phase 1 MVP/company record, a Phase 2 one-person AI-native asset-formation phase, and a Phase 3 professionalization path. These should not be mixed.
Original Mazzaneh MVP, execution team, product modules, users, businesses, transactions, analytics, and commercial logic. Used as execution and market evidence, not the solo claim.
Read Phase 1 →The bounded one-person claim: asset/IP formation, architecture, documentation, and methodology created without a human team, cofounder, agency, contractor stack, API stack, or agent workforce.
Read Phase 2 →The next stage: legal/IP/compliance review, technical validation, product rebuilds, pilots, licensing/JV options, selective team formation, and commercialization.
Read Phase 3 →These signals help orient the review, but they are not substitutes for diligence. The correct question is how much weight each signal carries after phase separation, evidence review, and independent validation.
The question is not whether MZN already has full Phase 3 validation. It does not claim that. The question is what credibility and challenge layers could reasonably exist during a deliberately one-person Phase 2 — and whether those layers justify serious independent review.
Crunchbase is not used as final proof, endorsement, valuation, or technical validation. It is included because, during Phase 2, it was one of the strongest credible external platform signals Mohammad could realistically access without PR, funding, media campaigns, paid business tools, or institutional amplification.
Ordinary profile mechanics may explain ordinary movement. They do not automatically explain a top global personal-profile signal under the reported absence of ordinary amplification levers.
Read the full validation logic →Festival and startup-program signals should be read as product-first and mostly Mazzaneh/Phase 1-rooted. They do not validate the full Phase 2 portfolio, but they show that selected visible product layers received unusually positive external response.
This distinction matters: Phase 1 can provide market/product evidence while Phase 2 remains the bounded one-person formation claim and Phase 3 remains the validation/professionalization path.
Open festival context →In a constrained one-person Phase 2, Mohammad could not reasonably build a conventional validation stack without weakening the solo-formation boundary. The responsible alternative was to build, document, preserve evidence, separate the phases, and invite fair challenge.
That is why MZN connects Crunchbase and recognition signals to challenge pages, not instead of them.
Open challenge path →Legal/IP review, technical diligence, commercial review, pilots, partner assessment, investor review, governance, and selective team formation are Phase 3 workstreams.
Their absence during a deliberately one-person Phase 2 is not automatically a weakness; it is partly the consequence of preserving the one-person formation boundary.
Read Phase 3 →This is the public surface of a documented portfolio. The interior pages carry the depth. Take the path below that matches how you evaluate — and read the depth before the reaction.
Mazzaneh produces the consent-first behavioral data. Zoyan is the wearable interface that turns intent into action in real time. BioCode is the theoretical substrate connecting the operating principles of biology to safer, embodied AGI. Each stands alone — together they describe a single architectural arc.
Twenty-two integrated modules that produce a consent-first behavioral data layer at meaningful scale. Production-validated. Live in market. The deeper architecture — not the surface UX — is the asset.
A smart-ring form factor with a voice-first AI assistant designed to orchestrate the Mazzaneh module surface. Hardware-and-software architecture is patent-grade. Form factor is intentional: the smallest, least intrusive surface that can support always-on intent capture with on-device wake-word and secure cloud handoff.
A four-layer framework treating physics, biology, consciousness, and AGI alignment as a single executable system. BioCode is the most important asset in the portfolio — and the only one whose complete framework has never been presented in public.
Most of the work in the body is not done by the brain. Trillions of autonomous cellular programs already know how to act locally. Embodiment is not a feature — it is the substrate of consciousness. A system without body, fear, pain, and real curiosity cannot be safely aligned, not because it would attack us, but because nothing would matter to it.
Bringing AI to a biological structure — the founding vision underneath BioCode.Embodiment is not a feature. It is the substrate of consciousness.
The LLM Complement Framework is the public-grade companion to the 21-slot anatomy of a frontier-grade AI organization. Each of the 13 sections names a structural requirement and locates MZN's position on it — Strong, Partial, or Gap — by reviewer-grade criteria.
HUAI is the meta-architectural framework underneath the entire portfolio. It answers four foundational questions: what a real LLM organization needs, what the prerequisites are, where a given case stands at each slot, and what should be built versus bought — with production-gating analysis per archetype (frontier lab · API provider · vertical app).
This page is designed as a public orientation layer, not a substitute for independent diligence. The goal is to make the claim boundaries visible before a reviewer goes deeper.
330+ assets is an entry signal, not the conclusion. The review should focus on depth, maturity, interconnection, evidence path, and which clusters survive diligence.
MZN does not claim that every product is 100% complete. The question is whether the documented and interconnected portfolio can justify serious strategic-value review.
patent-grade candidates and claim candidates require professional prior-art search, IP counsel review, claim drafting, and filing/secret/publication strategy.
Value language should be read as a public-layer strategic-value hypothesis for review, not a independently certified strategic-value frame, deal term, investment term, or final deal number.
Phase 1 users, sellers, transactions, team execution, and monetization design support execution evidence and market learning. They are not the valuation base for the Phase 2 solo asset stack.
The one-person claim applies to the deliberate Phase 2 formation window. Phase 1 team execution and Phase 3 professionalization should not be mixed with the solo formation claim.
Rankings, platform visibility, and third-party signals should be treated as dated recognition signals and reasons to review, not permanent status claims or substitutes for evidence.
AI, LLM, GPU, tokenizer, security, and BioCode materials should be reviewed by qualified technical or research evaluators, with sensitive layers handled through restricted or NDA review.
The public site is an orientation layer. Raw artifacts, provenance records, financial records, IP material, and sensitive technical details belong in restricted or NDA-only review.
MZN does not use the public landing page as a certified valuation, asking price, or investment term sheet. The portfolio should be reviewed through maturity, evidence, IP defensibility, reconstruction cost, strategic relevance, and buyer logic.
The central question is whether the documented, interconnected asset/IP stack can justify serious strategic-value review after independent diligence.
Any final valuation, deal structure, licensing model, or investment term belongs to Phase 3 with qualified legal, financial, technical, and commercial reviewers.
Assets should be evaluated by maturity level, evidence chain, novelty risk, productization path, partner fit, and what remains strong after challenge.
MZN is not asking to be accepted from a public pitch page. The public site is an orientation layer. The review package maps the case across skills, phase boundaries, evidence chains, evidence priorities, and role-based entry paths.
MZN has been mapped across the 12 skills of a one-person-unicorn framework as a provisional self-assessment, not a final external certification.
Open 12-Skill Evaluation →Converts the argument map into audit logic: claim type, evidence link, raw artifact, verification method, reviewer role, and disclosure level.
Open Diligence Q&A →Defines the 30-second to full-diligence reading ladder and identifies the top proof artifacts that should be reviewed first.
Open Compression Map →Explains why MZN should be reviewed by role: evaluator, product reviewer, AI reviewer, IP/legal reviewer, skeptic, investor, media, or research reviewer.
Open Review Architecture →A public method for testing the one-person AI-native company-formation claim without collapsing phases or using the wrong review lens.
Open Challenge Protocol →Explains how Phase 1 signals, Phase 2 AI-native architecture, and Phase 3 validation converge into Zoyan as the proposed human-facing interface.
Open Zoyan Convergence →The public independent-evaluation protocol: a structured path for review without relying on founder persuasion or a predetermined conclusion.
Open Evaluation Protocol →The public reader guide for understanding why the site is designed as a pitch deck, product map, and evidence-routing surface.
Open Reading Guide →The Recognition Gap is the analytical record of the distance between what has been documented in this portfolio and what existing recognition infrastructure is built to surface. The category for which this work was produced does not yet exist in the standard taxonomy of founders, of patents, or of awards — and the gap between artifact density and surface visibility is the page's subject.
Mohammad Rahimi · UID MRAI-2025-0001. A mechanical engineer with no formal computer-science background. Six years of work under sanctions, denied visas, no international banking, no physical presence at global events. The variable behind this portfolio is not the AI tool — it is the mind that wields it.
A mechanical engineer with an architect's mind. A solo builder under maximum constraint. Six years of work that the world is just beginning to see. The case isn't a product of AI's power — it's a product of an architect's mind with AI as a comprehensive executor.
Open the architect's profile 02 · Verify It YourselfEight probability prompts. Each structurally falsifiable. Run them against Claude, GPT, Gemini, or Grok. The pattern across four independent models has been consistent — but the result that matters is the one you produce.
Run the eight prompts 03 · Anticipated CritiqueFor two years, every challenge a critic could raise has been anticipated and answered. This is not a defense. It is an invitation to bring the strongest, most professional, most fair critique — and to verify a structured answer already exists.
See the 42 answersThe 21-slot capability anatomy on the IP portfolio page is the honest signal: 7 Strong · 13 Partial · 1 Gap. The Gaps fall outside the solo Phase 2 scope by design — they belong to the institutional Phase 3 now beginning.
No PR firm, no agency, no paid placement. Each signal is an institutional decision made by an external organization applying its own criteria.
This is the public layer of a layered disclosure model. The priced asset bands shown represent only the public-disclosable depth of each asset — operational details, complete patent claim sets, and the strongest IP layers are reserved for partnership-scope review under NDA. This is a capability demonstration, not a marketplace listing.
Materials are timestamped or anchored where applicable, blockchain-timestamped, and EUIPO-guided. Independent verification is welcomed at every step.
Phase 3 begins where Phase 2 ends. The selection of partners is in progress. Engagement is by reading the depth first — the materials below open a structured conversation.
Read the IP portfolio. Read the recognition gap. Then take a partnership-scope conversation forward through the contacts below — or open the partnership page directly.